Tissue engineering pursues the development of strategies to repair, regenerate or replace damaged or diseased tissue. In this study, fluorescently coated, ultrasmall superparamagnetic iron oxide nanoparticles (FLUSPIO) were used as a contrast enhancement for magnetic MRI of endothelial cells at the cellular level. The FLUSPIO exposure time and concentration in the medium were optimized with respect to the long-term cell viability and detectable MRI signal.
Introduction
Tissue engineering pursues the development of strategies to repair, regenerate or replace damaged or diseased tissue. Successful preclinical applications in this field have been shown for different cardiovascular implants [1] , [2] . The translation of tissue-engineered products into clinical routine is often limited by the lack of suitable non-invasive imaging methods to visualize parameters and behaviour of the constructs. Long-term non-destructive monitoring may simplify animal and clinical trials and reduce the number of needed animals. Recent studies have focused on a wide spectrum of imaging modalities to evaluate their suitability for applications in tissue engineering. Nelson et al. [3] published a pilot study demonstrating the feasibility of MRI for the evaluation of tissue engineered vascular grafts (TEVG) performance in vivo. In this case, human aortic smooth muscle cells were labelled with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. The cells were embedded in a small lumen TEVG and implanted into a mouse. The USPIO-labelled TEVG consistently appeared with sharper borders and registered lower T2 relaxation time values than the unseeded, unlabelled control scaffolds in vivo. In this study, fluorescently coated, ultrasmall superparamagnetic iron oxide nanoparticles (FLUSPIO) were used as a contrast enhancement for magnetic MRI of endothelial cells at the cellular level. The FLUSPIO exposure time and concentration in the medium were optimized with respect to the long-term cell viability and detectable MRI signal.
Methods

FLUSPIO nanoparticle preparation
Ultrasmall superparamagnetic iron oxide nanoparticles (FLUSPIO) were prepared at the Department of Experimental Molecular Imaging, RWTH Aachen. The FLUS-PIO were synthesized by coprecipitation of ferrous (Fe2+) and ferric (Fe3+) salts in aqueous alkaline conditions as described by Jayapaul et al. [4] .
Labeling efficiency determination
Uptake of FLUSPIO nanoparticles by ovine carotid artery endothelial cells occurred spontaneously after exposure to cells as a supplement to the culture medium. FLUSPIO stock solution (40 mM Fe) was diluted in the EBM growth medium to 0.1, 0.3, 1 and 3 mM iron, respectively. Endothelial cells were exposed to FLUSPIO for 10, 20, 30 minutes and 1, 2 and 3 hours. The efficiency of particle uptake and the permanence of intracellular iron was determined by Perl's Prussion blue staining and by MRI.
Biocompatibility testing
A series of biocompatibility assays was made, to study the influence of iron oxide internalization on endothelial cell proliferation, apoptosis and necrosis. All tests were carried out after direct exposure of the cells to the FLUSPIO. The evaluation of the long-term effect of FLUSPIO nanoparticles on the cells was performed at three different time points (day 1, 3 and 5).
Results
Labelling efficiency determination
Cells were stained for intracellular iron with Prussian blue after incubation time of 10, 20, 30 minutes and 1, 2 and 3 hours. As shown in Figure 1 , after 20 minutes of incubation, it was already possible to detect positive staining in the cytoplasm of the cells. The blue staining was delimited in small circles, possibly corresponding to the endosomes which engulfed the iron. One hour of incubation yielded a uniform distribution of the internalized iron and further incubation with FLUSPIO resulted in agglomerates which appeared as large dark blue spots in the cellular cytoplasm. Almost all cells stained positive for iron after 3 hours of incubation Magnetic resonance T1-and T2-weighted images of endothelial cells, incubated in medium with FLUSPIO particles of different concentrations and incubation times are presented in Figure 2 . These images show a well detectable difference between various labelling concentrations and incubation times. Furthermore, the difference between 1 and 3 hours of incubation time became clearly identifiable by calculating R2 relaxivities. 
Biocompatibility testing
Results of the cell proliferation test are shown in Figure 4 . The assay did not reveal any negative impact on endothelial cell viability and proliferation up to a concentration of 1 mM FLUSPIO. There was a significant decrease of cell viability after exposure to 3 mM FLUSPIO, however the cells seemed to recover at day 3, showing high proliferation rate. A positive effect on cell proliferation/viability after exposure to 0.3 and 1 mM FLUSPIO was observed.
Cell death after labelling with FLUSPIO particles was evaluated with ToxiLight® BioAssay (Lonza). A significant increase of cell necrosis was measured after 24 hours of exposure to FLUSPIO at a concentration of 3 mM. At day 3, no significant difference in cell necrosis was measured between cells exposed to FLUSPIO and negative control. At day 5, an increase was only observable in the case of exposure to 3 mM FLUSPIO. Apoptosis was detemined using the Caspase-Glo® 3/7 Assay (Promega). The measured luminescence signal was normalized to the positive control, for different FLUSPIO concentrations 24 hours, 3 days and 5 days after exposure. Furthermore, a significant increase in apoptosis 24 hours after exposure of FLUSPIO with 1 mM and 3 mM iron was observed (Figure 4c ).
Conclusion
This work presents the successful integration of MR contrast agents into endothelial cells and evaluates the effect of this labeling on MRI. Uptake and retention of fluorescently coated ultrasmall superparamagnetic iron oxide particles by endothelial were tested for several concentrations and incubation times. It was shown that high MR relaxivity could be obtained without adverse effects on the longterm cell viability. The results show the potential of using FLUSPIO for labeling the endothelium in TEVG. 
